These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9660)

  • 21. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies.
    Bonnet JJ; Chagraoui A; Protais P; Costentin J
    J Neural Transm; 1987; 69(3-4):211-20. PubMed ID: 3625193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of mepiprazole on central monoamine neurons. Evidence for increased 5-hydroxytryptamine and dopamine receptor activity.
    Fuxe K; Agnati LF; Ungerstedt U
    Eur J Pharmacol; 1976 Jan; 35(1):93-108. PubMed ID: 943291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amperozide, a putative anti-psychotic drug: uptake inhibition and release of dopamine in vitro in the rat brain.
    Eriksson E
    Life Sci; 1990; 47(23):2111-7. PubMed ID: 1979998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):382-94. PubMed ID: 1173528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VV; Grahovska T; Petkov VD; Konstantinova E
    Arzneimittelforschung; 1985; 35(12):1778-81. PubMed ID: 2420335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "In vitro" effect of some 5-hydroxy-indolalkylamine derivatives on monoamine uptake system.
    Morón JA; Perez V; Fernández-Alvarez E; Marco JL; Unzeta M
    J Neural Transm Suppl; 1998; 52():343-9. PubMed ID: 9564637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive inhibition of catecholamine uptake in synaptosomes of rat brain by rigid bicyclo-octanes.
    Wong DT; Bymaster FP; Reid LR
    J Neurochem; 1980 Jun; 34(6):1453-8. PubMed ID: 7381469
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the inhibitory effects of new non-tricyclic amine uptake inhibitors on the uptake of norepinephrine and 5-hydroxytryptamine into synaptosomes of the rat brain.
    Koide T; Uyemura K
    Neuropharmacology; 1980 Apr; 19(4):349-54. PubMed ID: 7383280
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of biogenic amines uptake by imipramine, desipramine, 2 OH-imipramine and 2 OH-desipramine in rat brain.
    Javaid JI; Perel JM; Davis JM
    Life Sci; 1979 Jan; 24(1):21-8. PubMed ID: 763066
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of the ergot alkaloid elymoclavine on the level and turnover of biogenic monoamines in the rat brain.
    Petkov VD; Konstantinova E
    Arch Int Pharmacodyn Ther; 1986 May; 281(1):22-34. PubMed ID: 2428322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
    Xie Z; Westmoreland SV; Miller GM
    J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncompetitive amine uptake inhibition by the new antidepressant pridefine.
    DeMet EM; Vosmer G; Halaris AE
    J Neurochem; 1981 Mar; 36(3):917-23. PubMed ID: 7205281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.
    Waldmeier PC; Baumann P; Greengrass PM; Maître L
    Postgrad Med J; 1976; 52(3 suppl):33-9. PubMed ID: 785423
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotropic drugs and dopamine uptake inhibition.
    Halaris AE; Freedman DX
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():247-58. PubMed ID: 3829
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.